Skip to Content

The White House is threatening the patents of high-priced drugs developed with taxpayer dollars

By AMANDA SEITZ and ZEKE MILLER
Associated Press

WASHINGTON (AP) — The Biden administration is putting pharmaceutical companies on notice. Washington is warning them that if the price of certain drugs is too high, the government might cancel their patent protection and allow rivals to make their own versions. Under a plan announced Thursday, the government would consider overriding the patent for high-priced drugs that have been developed with the help of taxpayer money and letting competitors make them in hopes of driving down the cost. The administration did not immediately release details about how the process will work and how it will deem a drug costly enough to act. If the plan is enacted, drugmakers are almost certain to sue.

Article Topic Follows: AP National

Jump to comments ↓

Author Profile Photo

Associated Press

BE PART OF THE CONVERSATION

KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content